Research
Grants
IMAGING INFLAMMATION AND TAU IN ELDERS WITH DIFFERENT CLINICAL AND BIOMARKER PROFILES OF ALZHEIMER S DISEASE (Federal Gov)
Apr 1 2016 - Mar 31 2021
A 12-WEEK, MULTICENTER, RANDOMIZED, PARALLEL-GROUP STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACOKINETICS, BIOMARKER EFFECTS, EFFICACY, AND EFFECT ON MICROGLIA ACTIVATION, AS MEASURED BY POSITRON EMISSION TOMOGRAPHY, OF AZD3241 IN (P&S Industry Clinical Trial)